GV-58(1毫克)產(chǎn)品是GV-58 is a Roscovitine (Cat. No. 1950) derivative that acts as a selective N- and P/Q-type Ca2?-channel agonist. These Ca22?-channels regulate transmitter release in synapses. Potential lead compound for a variety of disorders that result in neuromuscular weakness.